Articles By Keyword

. "Assessing model fit in joint models of longitudinal and survival data with applications to cancer clinical trials.." Stat Med. 2014;33(27):4715-33. Pub Med
. "Incorporating functional information in tests of excess De Novo mutational load.." Am J Hum Genet. 2015;97(2):272-83. Pub Med
. "Data for cancer comparative effectiveness research: past, present, and future potential.." Cancer. 2012;118(21):5186-97. Pub Med
. "Reporting and guidelines in propensity score analysis: A systematic review of cancer and cancer surgical studies.." J Natl Cancer Inst. 2017;109(8):. Pub Med
. "Translational studies of phenotypic probes for the mononuclear phagocyte system and liposomal pharmacology.." J Pharmacol Exp Ther. 2013;347(3):599-606. Pub Med
. "Localized differences in caudate and hippocampal shape are associated with schizophrenia but not antipsychotic type.." Psychiatry Res. 2013;211(1):1-10. Pub Med
. "Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial.." Lancet Oncol. 2017;18(6):732-742. Pub Med
. "A penalized likelihood approach for investigating gene-drug interactions in pharmacogenetic studies.." Biometrics. 2015;71(2):529-37. Pub Med
. "A general framework for studying genetic effects and gene-environment interactions with missing data.." Biostatistics. 2010;11(4):583-98. Pub Med
. "Combining an evolution-guided clustering algorithm and haplotype-based LRT in family association studies.." BMC Genet. 2011;12():48. Pub Med
. "Analysis of untyped SNPs: Maximum likelihood and imputation methods.." Genet Epidemiol. 2010;34(8):803-15. Pub Med
. "Evaluating haplotype effects in case-control studies via penalized-likelihood approaches: Prospective or retrospective analysis?." Genet Epidemiol. 2010;34(8):892-911. Pub Med
. "Genome-wide association study identifies five new schizophrenia loci.." Nat Genet. 2011;43(10):969-76. Pub Med
. "Biomarker threshold adaptive designs for survival endpoints.." J Biopharm Stat. 2018;28(6):1038-1054. Pub Med
. "Estimation of treatment effects and model diagnostics with two-way time-varying treatment switching: an application to a head and neck study.." Lifetime Data Anal. 2020;26(4):685-707. Pub Med
. "Joint modeling of survival time and longitudinal outcomes with flexible random effects.." Lifetime Data Anal. 2018;24(1):126-152. Pub Med
. "Assessing temporal agreement between central and local progression-free survival times.." Stat Med. 2015;34(5):844-58. Pub Med
. "Survival benefit of lung transplantation in the modern era of lung allocation.." Ann Am Thorac Soc. 2017;14(2):172-181. Pub Med
. "Genetic analyses of diverse populations improves discovery for complex traits.." Nature. 2019;570(7762):514-518. Pub Med
. "Data for cancer comparative effectiveness research: past, present, and future potential.." Cancer. 2012;118(21):5186-97. Pub Med
. "Genetic analyses of diverse populations improves discovery for complex traits.." Nature. 2019;570(7762):514-518. Pub Med
. "Genetic association analysis under complex survey sampling: the Hispanic Community Health Study/Study of Latinos.." Am J Hum Genet. 2014;95(6):675-88. Pub Med
. "Enrollment trends and disparity among patients with lung cancer in national clinical trials, 1990 to 2012.." J Clin Oncol. 2016;34(33):3992-3999. Pub Med
. "Efficient estimation for accelerated failure time model under case-cohort and nested case-control sampling.." Biometrics. 2017;73(1):114-123. Pub Med
. "The analysis of multivariate longitudinal data: a review.." Stat Methods Med Res. 2014;23(1):42-59. Pub Med
. "Clinical characteristics, response to exercise training, and outcomes in patients with heart failure and chronic obstructive pulmonary disease: findings from Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION).." Am Heart J. 2013;165(2):193-9. Pub Med
. "A moment-adjusted imputation method for measurement error models.." Biometrics. 2011;67(4):1461-70. Pub Med
. "Semiparametric regression for the weighted composite endpoint of recurrent and terminal events.." Biostatistics. 2016;17(2):390-403. Pub Med
. "Ten-year experience with extended criteria cardiac transplantation.." Circ Heart Fail. 2013;6(6):1230-8. Pub Med
. "Pharmacogenomics as a risk mitigation strategy for chemotherapeutic cardiotoxicity.." Pharmacogenomics. 2013;14(2):205-13. Pub Med
. "Ten-year experience with extended criteria cardiac transplantation.." Circ Heart Fail. 2013;6(6):1230-8. Pub Med
. "An Expectation Maximization algorithm for fitting the generalized odds-rate model to interval censored data.." Stat Med. 2017;36(7):1157-1171. Pub Med
. "Bayesian design of superiority clinical trials for recurrent events data with applications to bleeding and transfusion events in myelodyplastic syndrome.." Biometrics. 2014;70(4):1003-13. Pub Med
. "Inference on treatment effects from a randomized clinical trial in the presence of premature treatment discontinuation: the SYNERGY trial.." Biostatistics. 2011;12(2):258-69. Pub Med
. "Ascertainment, classification, and impact of neoplasm detection during prolonged treatment with dual antiplatelet therapy with prasugrel vs. clopidogrel following acute coronary syndrome.." Eur Heart J. 2016;37(4):412-22. Pub Med
. "Duration of eptifibatide infusion after percutaneous coronary intervention and outcomes among high-risk patients with non-ST-segment elevation acute coronary syndrome: insights from EARLY ACS.." Eur Heart J Acute Cardiovasc Care. 2013;2(3):246-55. Pub Med
. "Multivariate recurrent events in the presence of multivariate informative censoring with applications to bleeding and transfusion events in myelodysplastic syndrome.." J Biopharm Stat. 2014;24(2):429-42. Pub Med
. "Sample size estimation in educational intervention trials with subgroup heterogeneity in only one arm.." Stat Med. 2013;32(12):2140-54. Pub Med
. "Inference on treatment effects from a randomized clinical trial in the presence of premature treatment discontinuation: the SYNERGY trial.." Biostatistics. 2011;12(2):258-69. Pub Med
. "Mixed model analysis of censored longitudinal data with flexible random-effects density.." Biostatistics. 2012;13(1):61-73. Pub Med
. "Sample size estimation in educational intervention trials with subgroup heterogeneity in only one arm.." Stat Med. 2013;32(12):2140-54. Pub Med
. "Bayesian probability of success for clinical trials using historical data.." Stat Med. 2015;34(2):249-64. Pub Med
. "Bayesian probability of success for clinical trials using historical data.." Stat Med. 2015;34(2):249-64. Pub Med
. "Multivariate phenotype association analysis by marker-set kernel machine regression.." Genet Epidemiol. 2012;36(7):686-95. Pub Med
. "Bayesian probability of success for clinical trials using historical data.." Stat Med. 2015;34(2):249-64. Pub Med
. "Meta-analysis for discovering rare-variant associations: Statistical methods and software programs.." Am J Hum Genet. 2015;97(1):35-53. Pub Med
. "Integrative pipeline for profiling DNA copy number and inferring tumor phylogeny.." Bioinformatics. 2018;34(12):2126-2128. Pub Med
. "bcSeq: an R package for fast sequence mapping in high-throughput shRNA and CRISPR screens.." Bioinformatics. 2018;34(20):3581-3583. Pub Med
. "Improved detection of epigenomic marks with mixed effects hidden Markov models.." Biometrics. 2019;75(4):1401-1413. Pub Med
. "Hypothesis testing at the extremes: fast and robust association for high-throughput data.." Biostatistics. 2015;16(3):611-25. Pub Med